BlackRock Global Funds -opean Equity Income Fund SR2 (USD)Register to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | -5.7 | 12.3 | 5.8 | |
+/-Cat | - | - | -2.5 | 1.3 | 1.5 | |
+/-B’mrk | - | - | -9.4 | 0.9 | 0.3 | |
Category: Europe Equity Income | ||||||
Category Benchmark: Morningstar DM Eur Div Yld ... |
Key Stats | ||
NAV 21/11/2024 | USD 13.17 | |
Day Change | 0.50% | |
Morningstar Category™ | Europe Equity Income | |
ISIN | LU2319963208 | |
Fund Size (Mil) 31/10/2024 | EUR 1461.32 | |
Share Class Size (Mil) 21/11/2024 | EUR 3.18 | |
Max Initial Charge | - | |
Ongoing Charge 18/08/2023 | 0.93% |
Investment Objective: BlackRock Global Funds -opean Equity Income Fund SR2 (USD) |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests at least 70% of its total assets in equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andreas Zoellinger 03/12/2010 | ||
Brian Hall 01/03/2021 | ||
Inception Date 21/04/2021 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur Div Yld >2.5% NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds -opean Equity Income Fund SR2 (USD) | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.27 |
Enel SpA | Utilities | 4.05 |
Compagnie de Saint-Gobain SA | Industrials | 3.24 |
AstraZeneca PLC | Healthcare | 3.21 |
UniCredit SpA | Financial Services | 3.18 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds -opean Equity Income Fund SR2 (USD) |